| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $71.5M | +5.4% |
| SG&A Expense | $23.7M | +0.3% |
| Operating Income | -$95.2M | -4.1% |
| Pre-tax Income | -$94.0M | -10.3% |
| Income Tax | $1.4M | +69.4% |
| Net Income | -$95.5M | -10.9% |
| EPS (Basic) | -$1.45 | +26.8% |
| EPS (Diluted) | -$1.45 | +26.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $60.0M | -58.1% |
| Current Assets | $65.0M | -55.9% |
| Total Assets | $67.7M | -55.1% |
| Current Liabilities | $19.5M | +24.0% |
| Long-term Debt | $0 | — |
| Total Liabilities | $20.7M | +17.8% |
| Stockholders' Equity | $47.0M | -64.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$82.3M | -14.8% |
| Capital Expenditures | $44K | -86.4% |
| Investing Cash Flow | -$44K | +86.4% |
| Financing Cash Flow | $71.9M | +0.0% |
| Free Cash Flow | -$82.4M | -14.3% |